P Müller

Galectin‐9 and CXCL10 as Biomarkers for Disease Activity in Juvenile Dermatomyositis: A Longitudinal Cohort Study and Multicohort Validation

Judith Wienke, Felicitas Bellutti Enders, Johan Lim et al. · Arthritis & Rheumatology · 2019 · 87 citations · Full text

High efficacy of rituximab for myasthenia gravis: a comprehensive nationwide study in Austria

Raffi Topakian, Fritz Zimprich, Stephan Iglseder et al. · Journal of Neurology · 2019 · 82 citations

High Efficacy, Dermatology, Medicine +2

Siglec-1 expression on monocytes is associated with the interferon signature in juvenile dermatomyositis and can predict treatment response

Butsabong Lerkvaleekul, Saskia R Veldkamp, Marlot van der Wal et al. · Lara D. Veeken · 2021 · 52 citations · Full text

Identification of an Amino Acid Motif in <scp>HLA</scp>–<scp>DR</scp>β1 That Distinguishes Uveitis in Patients With Juvenile Idiopathic Arthritis

Anne‐Mieke J. W. Haasnoot, Marco W. Schilham, Sylvia Kamphuis et al. · Arthritis & Rheumatology · 2018 · 44 citations · Full text

Endothelial and Inflammation Biomarker Profiles at Diagnosis Reflecting Clinical Heterogeneity and Serving as a Prognostic Tool for Treatment Response in Two Independent Cohorts of Patients With Juvenile Dermatomyositis

Judith Wienke, Lauren M. Pachman, Gabrielle Morgan et al. · Arthritis & Rheumatology · 2020 · 40 citations · Full text